Koch Institute Symposium 2023

Cancer Vaccines, 21st Annual Koch Institute Symposium, Friday, June 23, 2023

Join us for the 21st Annual Cancer Research Symposium hosted by MIT's Koch Institute for Integrative Cancer Research on Friday, June 23, 2023. Academics and industry professionals are invited to explore issues in cancer vaccines with speakers who are leaders in the field. 

Agenda

9:00 AMOpening Remarks

Matthew Vander Heiden, PhD
Koch Institute for Integrative Cancer Research at MIT


9:15 AM Keynote Address

Federica Sallusto

Federica Sallusto, PhD
ETH Zürich, Switzerland 


10:00AMSession 1: Identification of cancer targets

Session chair: Stefani Spranger, PhD
Koch Institute for Integrative Cancer Research at MIT

Michal Bassani-Sternberg

Michal Bassani-Sternberg, PhD
Centre Hospitalier Universitaire Vaudois,  Lausanne, Switzerland

Tyler Jacks

Tyler Jacks, PhD
Koch Institute for Integrative Cancer Research at MIT

Charles Swanton

Mechanism of action and inflammatory axis for air pollution induced non-small cell lung cancer
Charles Swanton, PhD
Francis Crick Institute, London, UK


12:00pmSession 2: Panel Discussion

Panel Chair: Darrell Irvine, PhD
Koch Institute for Integrative Cancer Research at MIT

Robert Langer

Robert Langer, PhD

MIT Institute Professor,  Koch Institute for Integrative Cancer Research at MIT

Paul Burton

Paul Burton, MD, PhD
Chief Medical Officer, Moderna 

Catherine Wu

Catherine J. Wu, MD
Dana-Farber Cancer Institute


1:00 PMLunch break

(Lunch not provided)


2:30 PMSession 3: Immunobiology of cancer vaccines

Session chair: Stefani Spranger, PhD
Koch Institute for Integrative Cancer Research at MIT

Olivera Finn

Vaccines for prevention of non-viral cancers
Olivera Finn, PhD
Distinguished Professor of Immunology and Surgery, University of Pittsburgh School of Medicine

Stefani Spranger

Stefani Spranger, PhD
Koch Institute for Integrative Cancer Research at MIT

Pete DeMuth

Pete DeMuth, PhD
Chief Scientific Officer, Elicio Therapeutics


4:00 PMClosing Remarks

Matthew Vander Heiden, PhD
Koch Institute for Integrative Cancer Research at MIT

Thank you to our sponsors:

Platinum

Elicio Therapeutics
Royalty Pharma

Gold

Dragonfly

Silver

Agilent
Leap Therapeutics
nanoString
New England BioLabs Inc.
Repertoire Immune Medicines

Bronze

Abcam: Progress happens together
Ankyra
Cell signaling technology